X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29308) 29308
Publication (1600) 1600
Newspaper Article (368) 368
Book Review (302) 302
Book / eBook (96) 96
Magazine Article (71) 71
Book Chapter (54) 54
Newsletter (35) 35
Conference Proceeding (14) 14
Trade Publication Article (12) 12
Report (6) 6
Data Set (3) 3
Dissertation (3) 3
Paper (3) 3
Transcript (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26055) 26055
female (15838) 15838
male (15211) 15211
antineoplastic combined chemotherapy protocols - therapeutic use (12574) 12574
oncology (11927) 11927
vincristine - administration & dosage (10902) 10902
middle aged (10886) 10886
adult (10516) 10516
index medicus (9893) 9893
chemotherapy (8565) 8565
aged (8292) 8292
cyclophosphamide - administration & dosage (7615) 7615
doxorubicin - administration & dosage (7049) 7049
hematology (6364) 6364
treatment outcome (5668) 5668
cancer (5631) 5631
adolescent (5295) 5295
prednisone - administration & dosage (5105) 5105
antineoplastic combined chemotherapy protocols - administration & dosage (4672) 4672
combined modality therapy (4486) 4486
child (4306) 4306
prognosis (4049) 4049
antineoplastic combined chemotherapy protocols - adverse effects (3897) 3897
child, preschool (3300) 3300
animals (3299) 3299
dose-response relationship, drug (3215) 3215
antineoplastic agents - administration & dosage (3137) 3137
methotrexate - administration & dosage (2979) 2979
therapy (2950) 2950
care and treatment (2925) 2925
retrospective studies (2830) 2830
etoposide - administration & dosage (2784) 2784
disease-free survival (2672) 2672
follow-up studies (2610) 2610
remission induction (2600) 2600
neoplasm staging (2462) 2462
survival rate (2419) 2419
drug administration schedule (2334) 2334
rituximab (2310) 2310
lymphomas (2276) 2276
pharmacology & pharmacy (2228) 2228
survival analysis (2218) 2218
medicine & public health (2189) 2189
antineoplastic agents - therapeutic use (2180) 2180
aged, 80 and over (2159) 2159
infant (2156) 2156
radiotherapy (2143) 2143
time factors (2099) 2099
cisplatin - administration & dosage (2070) 2070
vincristine (2056) 2056
pediatrics (2054) 2054
drug therapy, combination (2030) 2030
bleomycin - administration & dosage (2007) 2007
children (1876) 1876
survival (1860) 1860
non-hodgkins-lymphoma (1816) 1816
cyclophosphamide (1813) 1813
research (1804) 1804
transplantation (1772) 1772
vincristine - adverse effects (1747) 1747
vincristine - therapeutic use (1743) 1743
lymphoma, non-hodgkin - drug therapy (1720) 1720
drug therapy (1683) 1683
doxorubicin (1606) 1606
risk factors (1605) 1605
tumors (1584) 1584
dosage and administration (1576) 1576
cytarabine - administration & dosage (1542) 1542
mice (1539) 1539
recurrence (1530) 1530
health aspects (1511) 1511
analysis (1487) 1487
young adult (1478) 1478
procarbazine - administration & dosage (1473) 1473
clinical trials as topic (1457) 1457
radiotherapy dosage (1429) 1429
lymphoma, large b-cell, diffuse - drug therapy (1427) 1427
lung neoplasms - drug therapy (1417) 1417
antineoplastic agents - adverse effects (1395) 1395
leukemia (1383) 1383
prospective studies (1377) 1377
hodgkin disease - drug therapy (1340) 1340
patients (1338) 1338
lymphoma (1325) 1325
drug dosages (1282) 1282
prednisolone - administration & dosage (1267) 1267
trial (1267) 1267
dexamethasone - administration & dosage (1250) 1250
cyclophosphamide - therapeutic use (1243) 1243
cyclophosphamide - adverse effects (1213) 1213
surgery (1192) 1192
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1188) 1188
multiple myeloma - drug therapy (1184) 1184
multiple myeloma (1180) 1180
doxorubicin - adverse effects (1170) 1170
antineoplastic agents (1162) 1162
high-dose chemotherapy (1143) 1143
etoposide (1126) 1126
hematology, oncology and palliative medicine (1100) 1100
doxorubicin - therapeutic use (1091) 1091
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Scarborough Hospital - Hospital Department (2) 2
UTL at Downsview - May be requested (2) 2
Chemistry (A D Allen) - Reference (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Reference (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28611) 28611
Japanese (517) 517
German (334) 334
Russian (238) 238
French (235) 235
Polish (193) 193
Spanish (148) 148
Chinese (79) 79
Italian (57) 57
Hungarian (22) 22
Czech (15) 15
Hebrew (13) 13
Dutch (12) 12
Serbian (10) 10
Portuguese (9) 9
Croatian (7) 7
Finnish (4) 4
Bulgarian (3) 3
Danish (3) 3
Turkish (3) 3
Ukrainian (3) 3
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 09/2013, Volume 162, Issue 5, pp. 631 - 638
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 4, pp. 848 - 858
BACKGROUND. Pegylated liposomal doxorubicin has pharmacologic and safety advantages over conventional doxorubicin. METHODS. For this noninteriority trial, 192... 
Dexamethasone | Neutropenic fever | Drug toxicity | Multiple myeloma | Liposomes | Drug resistance | Doxorubicin | Pegylated liposomal doxorubicin | Vincristine | Neoplasms | dexamethasone | 1ST-LINE TREATMENT | multiple myeloma | vincristine | ONCOLOGY-GROUP | liposomes | COMBINATION THERAPY | neutropenic fever | CONVENTIONAL DOXORUBICIN | TRANSPLANTATION | pegylated liposomal doxorubicin | THALIDOMIDE PLUS DEXAMETHASONE | KAPOSIS-SARCOMA | ONCOLOGY | drug toxicity | REDUCED-DOSE DEXAMETHASONE | VAD | doxorubicin | drug resistance | neoplasms | DVD-T | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Fever - chemically induced | Multiple Myeloma - drug therapy | Doxorubicin - analogs & derivatives | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Administration, Oral | Catheterization, Central Venous | Treatment Outcome | Polyethylene Glycols - administration & dosage | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Infusions, Intravenous | Doxorubicin - adverse effects | Pharmaceutical research | Drugs | Myelocytic leukemia | Reports | Nonlymphoid leukemia | Research | Drug therapy, Combination | Drug therapy | Health aspects
Journal Article
Journal Article
by Gnekow, Astrid K and Walker, David and Walker, David A and Kandels, Daniela and Picton, Susan and Picton, Sue and Giorgio Perilongo and Grill, Jacques and Stokland, Tore and Sandstrom, Per Erik and Sandstrom, Per Eric and Warmuth-Metz, Monika and Pietsch, Torsten and Giangaspero, Felice and Schmidt, René and Faldum, Andreas and Kilmartin, Denise and De Paoli, Angela and De Salvo, Gian Luca and Slavc, Irene and Perilongo, Giorgio and Clausen, Niels and Arola, Mikko and Jonsson, Olafur Gisli and Cruz, Ofelia and Navajas, Aurora and Teijeiro, Anna and Kalifa, Chantal and Raquin, Marie-Anne and Verlooy, Joris and Hans, Volkmar and Scheurlen, Wolfram and Hainfellner, Johannes and Ironside, James and Robson, Keith and Skullerud, Kari and Scheie, David and NN and Ruchoux, Marie-Madeleine and Jouvet, Anne and Figarella-Branger, Dominique and Lellouch-Toubiana, Arielle and Prayer, Daniela and Calderone, Milena and Jaspan, Tim and Bakke, Soren Jacob and Vazquez, Eli and Couanet, Dominique and Kortmann, Rolf D and Diekmann, Karin and Scarzello, Giovanni and Taylor, Roger and Lote, Knut and Giralt, Jordi and Carrie, Christian and Habrand, Jean Louis and Soerensen, Niels and Czech, Thomas and Chumas, Paul and Gustavson, Bengt and Zerah, Michel and Wabbels, Bettina and Pinello, Maria Luisa and Fielder, Alistair and Simmons, Ian and Christoffersen, Terje and Calaminus, Gabriele and Brockmann, Knut and Straeter, Ronald and Ebinger, Friedrich and Hernaiz-Driever, Pablo and Lackner, Herwig and Kennedy, Colin and Glaser, Adam and Stromberg, Bo and Indiano, Jose Ma and Rodary, Chantal and Bouffet, Eric and Frappaz, Didier and Emser, Angela and Stephens, Suzanne and Machin, David and Le Deley, Marie-Cécile and Egeland, Thore and Freemann, Carolyn and Schrappe, Martin and Sposto, Richard and Low Grade Glioma Consortium and of the Low Grade Glioma Consortium and the participating centers and Medicinska fakulteten and Institutionen för klinisk vetenskap and Pediatrik and Umeå universitet
European Journal of Cancer, ISSN 0959-8049, 08/2017, Volume 81, pp. 206 - 225
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 14, pp. 1344 - 1355
Journal Article
Cancer, ISSN 0008-543X, 07/2012, Volume 118, Issue 13, pp. 3294 - 3301
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 8, pp. 783 - 790
Journal Article